Advertisement
Screener

PRO-DEX, INC. (PDEX) Overview

PRO-DEX, INC. (PDEX) Overview

  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 1.20; Beat / miss (m).
  • 1 Oct 2025: Period ending 31 Dec 2025; Estimate (m); Actual 0.66; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual 1.40; Beat / miss (m).
  • 1 Jan 2025: Period ending 31 Mar 2025; Estimate (m); Actual 0.98; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$27.46$33.76$41.50$51.01$62.71$77.082025-11-062026-11-06$12.50$17.99$25.88$37.24$53.57$77.082021-11-082026-11-06$3.89$7.08$12.86$23.35$42.43$77.082016-11-072026-11-06$0.77$1.93$4.86$12.21$30.68$77.082006-11-062026-11-06$0.36$1.06$3.09$9.02$26.37$77.081986-08-072026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$63.16
Previous close
$70.02
Change
-$6.86
Change (%)
-9.80%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

PDEX
+81.96%
S&P 500
(m)

1 year

PDEX
+106.55%
S&P 500
(m)

3 years

PDEX
+345.99%
S&P 500
(m)

5 years

PDEX
+173.94%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

31 Mar 2026 ○ Estimate (m) ● Actual 1.20

0.530.791.051.321.5831 Dec 2024: estimate (m); actual 0.6131 Dec 2024(m)31 Mar 2025: estimate (m); actual 0.9831 Mar 2025(m)30 Sept 2025: estimate (m); actual 1.4030 Sept 2025(m)31 Dec 2025: estimate (m); actual 0.6631 Dec 2025(m)31 Mar 2026: estimate (m); actual 1.2031 Mar 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202631 Mar 2026(m)1.20(m)(m)
1 Oct 202531 Dec 2025(m)0.66(m)(m)
1 Jul 202530 Sept 2025(m)1.40(m)(m)
1 Jan 202531 Mar 2025(m)0.98(m)(m)
1 Oct 202431 Dec 2024(m)0.61(m)(m)

30 Jun 2026 ○ Estimate (m) ● Actual 4.12

0.521.462.413.354.3030 Jun 2022: estimate (m); actual 1.2130 Jun 2022(m)30 Jun 2023: estimate (m); actual 1.9530 Jun 2023(m)30 Jun 2024: estimate (m); actual 0.6030 Jun 2024(m)30 Jun 2025: estimate (m); actual 2.6730 Jun 2025(m)30 Jun 2026: estimate (m); actual 4.1230 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jul 202530 Jun 2026(m)4.12(m)(m)
1 Jul 202430 Jun 2025(m)2.67(m)(m)
1 Jul 202330 Jun 2024(m)0.60(m)(m)
1 Jul 202230 Jun 2023(m)1.95(m)(m)
1 Jul 202130 Jun 2022(m)1.21(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 20.41M* ■ Earnings 2.86M* — Profit margin 14.00%*

-2.45M10.7%5.99M15.9%14.42M21.1%22.85M26.3%30 Sept 2025: revenue 18.53M; earnings 4.68M; profit margin 25.26%30 Sept 202531 Dec 2025: revenue 18.66M; earnings 2.19M; profit margin 11.72%31 Dec 202531 Mar 2026: revenue 19.95M; earnings 3.94M; profit margin 19.74%31 Mar 202630 Jun 2026: revenue 20.41M*; earnings 2.86M*; profit margin 14.00%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2026-04-01 to 2026-06-30; USD.30 Jun 2026

30 Jun 2026 ■ Revenue 77.55M ■ Earnings 13.66M — Profit margin 17.62%

-9.31M3.0%22.75M8.2%54.80M13.4%86.85M18.6%30 Jun 2023: revenue 46.09M; earnings 7.07M; profit margin 15.35%30 Jun 202330 Jun 2024: revenue 53.84M; earnings 2.13M; profit margin 3.95%30 Jun 202430 Jun 2025: revenue 66.59M; earnings 8.98M; profit margin 13.48%30 Jun 202530 Jun 2026: revenue 77.55M; earnings 13.66M; profit margin 17.62%30 Jun 2026

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$63.16(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$63.16High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning PDEX

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-12; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$13.66M
Profit margin
17.62%
Return on assets · 12 month
20.14%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
206.00
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
81.38K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-3.30%*
Total return · month
11.92%*
Total return · quarter
19.90%*
Total return · half year
42.96%*
Total return · year to date
81.96%*
Total return · 1 year
106.55%*
Total return · 3 years
345.99%*
Total return · 5 years
173.94%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$77.55M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

PRO-DEX, INC. Overview

View more →

(m)

(m)

SEC CIK
788920
Industry (SIC)
3841 Surgical & Medical Instruments & Apparatus
Country of operation
United States
Business address
2361 MCGAW AVENUE, IRVINE, California, 92614, United States
Fiscal year end
0630
Phone
949-769-3231

Similar stocks

Stock NameCountryMarket CapPE Ratio
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
Neuronetics, Inc. (STIM)United States$0.216B-3.25
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
Profound Medical Corp. (PROF)$0.206B-7.37
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Cytosorbents Corp (CTSO)United States$0.274B-1.29
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Mobia Medical, Inc. (MOBI)United States$0.293B
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32